🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Formulation C

Found 0 matching trials

Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults

PHASE1

This two part study will evaluate the safety and immunogenicity of two form...

Status

Completed

Location

Americaninhas Vaccine Center

Start Date

2011-11

Trial ID

NCT01261130

Treatments Being Tested

10 μg Na-GST-1/Alhydrogel 30 μg Na-GST-1/Alhydrogel 100 μg Na-GST-1/Alhydrogel 10 μg Na-GST-1/ Alhydrogel/GLA-AF 30 μg Na-GST-1/Alhydrogel/GLA-AF 100 μg Na-GST-1/Alhydrogel/GLA-AF Butang® hepatitis B vaccine

Bioequivalence Study to Evaluate the Impact of Varying Crystalline Polymorph Forms for the Commercial Oral Capsule Formulation of 10-mg Lenvatinib in Healthy Volunteers

PHASE1

This will be a randomized, single dose, open-label, three-treatment period ...

Status

Completed

Location

Multiple Locations

Start Date

2013-07

Trial ID

NCT02723630

Treatments Being Tested

Lenvatinib 10 mg

A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects.

PHASE1

This study will estimate the relative bioavailability of AZD5055 film-coate...

Status

Completed

Location

Research Site

Start Date

2022-11-04

Trial ID

NCT05630677

Treatments Being Tested

AZD5055 solution for infusion AZD5055 oral suspension AZD5055 film-coated tablet AZD5055 film-coated tablet Rabeprazole, Delayed-release tablet Rabeprazole, Delayed-release tablet

An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.

PHASE1

Sixteen healthy subjects will be randomized to each of the 3 parallel treat...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-10-15

Trial ID

NCT00996268

Treatments Being Tested

GSK2212836 GSK2212836

A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules.

PHASE1

Study to compare PK of a new 100mg capsule with four 25mg capsules. This is...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-07-02

Trial ID

NCT00728897

Treatments Being Tested

GSK598809 new formulation GSK598809 old formulation

Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers

PHASE2

The study was to evaluate the safety and and immune response of each of thr...

Status

Completed

Location

NZOZ Bioscience Sp zoo

Start Date

2011-09

Trial ID

NCT01434680

Treatments Being Tested

MenC-CRM LIQ MenC-CRM ROS MenC-CRM EMV

Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug

PHASE1

The purpose of this study is to evaluate retention and replacement of the O...

Status

Unknown

Location

Multiple Locations

Start Date

2013-02

Trial ID

NCT01800175

Treatments Being Tested

Punctum Plug

SMMART Adaptive Clinical Treatment (ACT) Trial

EARLY_PHASE1

SMMART-ACT is a feasibility pilot study to determine if testing samples fro...

Status

Withdrawn

Location

Multiple Locations

Start Date

2023-01-30

Trial ID

NCT05238831

Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor (PPI) Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects

PHASE1

Part 1 of the study will be conducted to provide additional information on ...

Status

Completed

Location

Quotient Sciences

Start Date

2018-03-21

Trial ID

NCT03464058

Treatments Being Tested

BOS172767 tablets BOS172767 liquid capsules BOS172767 micronized capsules BOS172767 immediate release capsules BOS172767 matching placebo capsules BOS172767 matching placebo tablets Rabeprazole

Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants

PHASE1

The purpose of this study is to evaluate the oral bioavailability of two ne...

Status

Completed

Location

Multiple Locations

Start Date

2015-03

Trial ID

NCT02396147

Treatments Being Tested

TAK-385 T2 Formulation TAK-385 T4 Formulation B TAK-385 T4 Formulation C

Previous Next